COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL

Aim. To compare two therapies based on carvedilol or metoprolol in hypertensive patients with overweight and obesity.Material and methods. 320 patients with arterial hypertension (1-2 degree) were involved in the study. 160 patients received carvedilol and 160 patients – metoprolol. Both randomized...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Veliganina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiselev, S. Yu. Levashov, V. A. Nevzorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnjukova, V. V. Yakusevich
Format: Artigo
Jezik:Inglês
Izdano: Stolichnaya Izdatelskaya Kompaniya 2016-01-01
Serija:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Teme:
arterial hypertension
overweight
obesity
beta-blockers
carvedilol
metoprolol
Online dostop:https://www.rpcardio.com/jour/article/view/617
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki